We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cel... ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory. Show more
Multiple patients treated across the U.S. with ANKTIVA less than eight weeks after FDA approval of first-in-class cytokine immunotherapy for BCG unresponsive non-muscle invasive bladder cancer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.99 | -13.6176066025 | 7.27 | 7.27 | 6.01 | 3134964 | 6.4256013 | CS |
4 | 0.09 | 1.45395799677 | 6.19 | 7.63 | 5.5055 | 4074589 | 6.50748347 | CS |
12 | 0.295 | 4.92898913952 | 5.985 | 10.53 | 4.73 | 7293035 | 7.23692845 | CS |
26 | 1.1 | 21.2355212355 | 5.18 | 10.53 | 3.12 | 5526164 | 6.23504124 | CS |
52 | 3.52 | 127.536231884 | 2.76 | 10.53 | 1.25 | 4913263 | 4.72993588 | CS |
156 | -7.58 | -54.6897546898 | 13.86 | 13.895 | 1.21 | 3075899 | 4.62528521 | CS |
260 | -30.27 | -82.8180574555 | 36.55 | 40.834 | 1.21 | 2906864 | 5.27902312 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions